Key result
The presence of subclinical carotid plaque was a powerful independent predictor of adverse cardiovascular outcomes in non-diabetic chronic kidney disease patients (OR 7.80).
Why the study?
Does subclinical carotid atherosclerosis predict adverse cardiovascular outcomes in asymptomatic non-diabetic chronic kidney disease patients?
Cohort (n=182)
No
Does subclinical carotid atherosclerosis predict adverse cardiovascular outcomes in asymptomatic non-diabetic chronic kidney disease patients?
Odds Ratio: 7.8 (95% CI 1.45–45.97)
Absolute Event Rate: 8.6% vs 1.5%
p-value: p=0.017
Subclinical carotid atherosclerosis, particularly the presence of carotid plaque, is a strong independent predictor of adverse cardiovascular outcomes in asymptomatic non-diabetic CKD patients and is closely associated with increased LV filling pressure.
May aid risk stratification in non-diabetic CKD; leaves open whether carotid imaging changes management or outcomes.
BACKGROUND: Non-diabetic chronic kidney disease (CKD) patients are a heterogeneous group with a variety of prognosis. We investigated the role of subclinical carotid atherosclerosis for the prediction of adverse cardiovascular (CV) outcomes in these patients, and tried to identify clinical and echocardiographic parameters associated with subclinical carotid atherosclerosis. METHODS: As a prospective design, 182 asymptomatic non-diabetic CKD patients underwent carotid ultrasonography and Doppler echocardiography. Carotid atherosclerosis was defined as a carotid intima-media thickness ≥1.0 mm and/or the presence of plaque. RESULTS: During the mean follow-up period of 28.8 ± 16.1 months, 23 adverse CV events occurred. Patients with carotid atherosclerosis (99, 54.4%) showed significantly higher rates of annual CV events than those without (8.6 vs. 1.5%, p <0.001). Particularly, the presence of carotid plaque was a powerful predictor of adverse CV outcomes (OR 7.80, 95% CI 1.45-45.97). Clinical parameters associated with the presence of subclinical carotid atherosclerosis were old age, previous history of hypertension, increased pulse pressure, and higher high-sensitivity C-reactive protein (hs-CRP) level. By echocardiography, early diastolic mitral annular velocity (E') and the ratio of early peak transmitral inflow velocity (E) to E' (E/E') were closely related with the presence of carotid atherosclerosis. A multivariate analysis showed that age, hs-CRP, and E/E' were significant determinants of carotid atherosclerosis. CONCLUSIONS: Carotid plaque, even subclinical, was closely associated with a poor prognosis in non-diabetic CKD patients. Increased age, hs-CRP level, and E/E' ratio may be useful markers suggesting the presence of carotid atherosclerosis in these patients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2013) conducted a cohort in Non-diabetic chronic kidney disease (n=182). Subclinical carotid atherosclerosis (carotid plaque) vs. Absence of carotid atherosclerosis/plaque was evaluated on Adverse cardiovascular events (fatal or non-fatal acute coronary syndrome or cerebrovascular events) (OR 7.80, 95% CI 1.45-45.97, p=0.017). The presence of subclinical carotid plaque was a powerful independent predictor of adverse cardiovascular outcomes in non-diabetic chronic kidney disease patients (OR 7.80).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: